Clinical trial
Quantitative Refractive Crosslinking in Presbyopia-Aged Patients: An Open Label, Multi-center, Phase I Study of the TECLens Corneal Crosslinking System for Correction of Refractive Error in Patients of Presbyopia Age
NCT07137767 is registered in ClinicalTrials.gov with TECLens, Inc. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Quantitative Refractive Crosslinking in Presbyopia-Aged Patients: An Open Label, Multi-center, Phase I Study of the TECLens Corneal Crosslinking System for Correction of Refractive Error in Patients of Presbyopia Age
- Lead sponsor
- TECLens, Inc.
- Phase
- Not applicable
- Overall status
- Not yet recruiting
- Start date
- August 31, 2025
- Completion date
- August 31, 2026
- Enrollment
- 25 (estimated)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.